Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation

MARLBOROUGH, Mass. and CHICAGO, Nov. 16, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Key findings from the study comparing the device to first-line oral anticoagulation (OAC) – including direct oral anticoagulants (DOAC) (95%) and warfarin (5%) – for stroke risk reduction in patients with non-valvular atrial fibrillation following a cardiac ablation were presented in a late-breaking science session at the American Heart Association's Scientific Sessions 2024, and simultaneously published in The New England Journal of Medicine.

NEW YORK, Nov. 16, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hasbro, Inc. (NASDAQ: HAS) between February 7, 2022 and October 25, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025.

RADNOR, Pa., Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) ("DENTSPLY").

On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products," and that its "decision was made in consultation with the U.S. Food and Drug Administration (FDA)." On this news, DENTSPLY's stock price fell $1.10 per share, or 4.51%, to close at $23.31 per share on October 25, 2024.

SAN RAFAEL, Calif., Nov. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced positive and consistent results from multiple real-world evidence studies of VOXZOGO® (vosoritide) in children with achondroplasia. These results, as well as data from the investigational research program for VOXZOGO in hypochondroplasia, were presented at the 62nd Annual European Society for Paediatric Endocrinology (ESPE) Meeting in Liverpool, England, Nov. 16-18, 2024.  

SAN DIEGO, Nov. 16, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ASML Holding N.V. (NASDAQ: ASML) ordinary shares between January 24, 2024 and October 15, 2024, both dates inclusive (the "Class Period"), have until January 13, 2025 to seek appointment as lead plaintiff of the ASML class action lawsuit. Captioned City of Hollywood Firefighters' Pension Fund v. ASML Holding N.V., No. 24-cv-08664 (S.D.N.Y.), the ASML class action lawsuit charges ASML and certain of ASML's top current and former executives with violations of the Securities Exchange Act of 1934.

RADNOR, Pa., Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Wolfspeed, Inc. (NYSE: WOLF) ("Wolfspeed").

On November 6, 2024, during after-market hours, Reuters published an article entitled "Chipmaker Wolfspeed projects revenue below estimates on weak auto demand, shares sink." Specifically, the article stated that Wolfspeed "forecast quarterly revenue below estimates on Wednesday and said it would book $174 million in restructuring charges for the planned closure of a facility, as the chipmaker deals with sluggish demand from automotive customers. [. . .] The company dropped plans last month to build a factory in Ensdorf, Germany, citing the slower adoption of EVs in Europe."

RADNOR, Pa., Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period")  The lead plaintiff deadline is December 13, 2024.

In a first-of-its-kind study, tirzepatide also alleviated heart failure symptoms and physical limitations

Patients on tirzepatide experienced improved exercise capacity, greater weight loss and reduced systemic inflammation

Lilly has initiated submissions for tirzepatide for the treatment of HFpEF and obesity to global regulatory agencies

INDIANAPOLIS, Nov. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the risk of worsening heart failure events in adults with heart failure with preserved ejection fraction (HFpEF) and obesity. Patients treated with tirzepatide also experienced notable improvements in heart failure symptoms and physical limitations. The results were published in The New England Journal of Medicine simultaneously with a presentation at the American Heart Association (AHA) Scientific Sessions 2024.

NEW YORK, Nov. 16, 2024 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bumble Inc. (NASDAQ: BMBL) between November 7, 2023 and August 7, 2024, both dates inclusive (the "Class Period"), of the important November 25, 2024 lead plaintiff deadline.

So what: If you purchased Bumble securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, Nov. 16, 2024 /PRNewswire/ -- 

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Match Group, Inc. (NASDAQ: MTCH) resulting from allegations that Match Group may have issued materially misleading business information to the investing public.

So What: If you purchased Match Group securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm reminds purchasers of securities of New Fortress Energy Inc. (NASDAQ: NFE) between February 29, 2024 and August 8, 2024, both dates inclusive (the "Class Period"), of the important November 18, 2024 lead plaintiff deadline.

So what: If you purchased New Fortress securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 23, 2024 to file lead plaintiff applications in a securities class action lawsuit against The Toronto-Dominion Bank ("TD" or the "Company") (NYSE: TD), if they purchased the Company's securities between February 29, 2024 to October 9, 2024, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company's securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period").  This action is pending in the United States District Court for the Middle District of Tennessee.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 13, 2025 to file lead plaintiff applications in a securities class action lawsuit against Hasbro, Inc. (NasdaqGS: HAS), if they purchased the Company's shares between February 7, 2022, and October 25, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

Get Help

Hasbro investors should visit us at https://claimsfiler.com/cases/nasdaq-has-1/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against Chipotle Mexican Grill, Inc. (NYSE: CMG), if they purchased the Company's shares between February 8, 2024 and October 29, 2024, inclusive (the "Class Period") or purchased Chipotle call options or sold put options during the Class Period. This action is pending in the United States District Court for the Central District of California.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 13, 2025 to file lead plaintiff applications in a securities class action lawsuit against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company's (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 2024 initial public offering ("IPO" or the "Offering"); and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Nov. 15, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 9, 2024 to file lead plaintiff applications in a securities class action lawsuit against EngageSmart, Inc. ("EngageSmart" or the "Company") (NYSE: ESMT), if they (1) purchased or otherwise acquired EngageSmart common stock between October 23, 2023 and January 26, 2024, or (2) held EngageSmart common stock as of the December 21, 2023 record date of the take-private acquisition of the Company (the "Merger") by Vista Equity Partners Management, LLC and its affiliates. This action is pending in the United States District Court for the District of Delaware.

COSTA MESA, Calif., Nov. 15, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB: GRAM) a leading vertically-integrated California cannabis company, today announced that Mark Castaneda has ended his service as a member of the Board of Directors of Gold Flora, effective November 30, 2024. Mr. Castaneda also served as the Chairman of the Audit Committee of the Board of Directors and a member of the Compensation Committee.

GUADALAJARA, Mexico, Nov. 15, 2024 /PRNewswire/ -- Grupo Simec, S.A.B. de C.V. (the "Company") today filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission at www.sec.gov.  The Form 20-F is also available on the investor relations section of the Company's website at https://gsimec.com.mx/sec-filings.php. Shareholders may request a hard copy of the Form 20-F, including the Company's complete audited financial statements for the year ended December 31, 2023, free of charge, by contacting the Company's Finance coordinator, Mario Moreno Cortez, by email at mmoreno@gruposimec.com.mx.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

WINNIPEG, MB, Nov. 15, 2024 /CNW/ - Marwest Apartment Real Estate Investment Trust ("Marwest Apartment REIT" or the "REIT") (TSXV: MAR.UN) announced that its Trustees have declared a monthly cash distribution of $0.0013 per trust unit ("Trust Unit") of the REIT for the month of November 2024, representing a cash distribution per Trust Unit of $0.0156 on an annualized basis. The cash distributions will be made on December 16, 2024 to Unitholders on record as of November 30, 2024.